Elevated Soluble Galectin-3 as a Marker of Chemotherapy Efficacy in Breast Cancer Patients: A Prospective Study

Table 1

Summary of patient characteristics for breast cancer patients enrolled in the study.

	Adjuvant ()	Neoadjuvant ()
Age (years)
Mean	45.8	44.1
Median	45	45.8
Range	28-65	20-62
Size (cm^3)
Mean	23.3	34.2
Median	19.3	15.9
Range	0.24-106.2	1.1-225
Axillary nodes ( (%))
Yes	36	18
No	14	14
Unknown	2	4
Genetic background ()
TRN	9	11
Her2+	6	8
ER+	20	11
HER2+/ER+	10	1
Unknown	7	5

Patient age, tumor size, type, grade, and metastatic status are given. TRN: triple negative; ER: estrogen receptor; PR: progesterone receptor; IDC: intraductal carcinoma; DCIS: ductal carcinoma in situ; LCA: lobular carcinoma.